Search results with tag "Oxaliplatin"
FOLFOX - Oxaliplatin / De Gramont - NECN
www.necn.nhs.ukFOLFOX - Oxaliplatin / De Gramont Cumbria, Northumberland, Tyne & Wear Area Team FOLFOX-CNTW-protocol-CRP09-CR007 V1.3 Page 1 of 4 …
GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for ...
www.londoncanceralliance.nhs.ukGEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for relapsed / refractory Lymphoma Page 1 of 4 Reason for Update: Network Protocol Development Approved by Consultant: P Fields 29/03/2012 Version: 1 Approved by Chair Haem TWG: Majid Kazmi
SUMMARY OF PRODUCT CHARACTERISTICS 1 …
www.sanofi-aventis.co.ukReference: 67128 2011-10-13 - DSPC - Datapharm SPC 0.1 Oxaliplatin is contraindicated in patients who - have a known history of hypersensitivity to oxaliplatin.
BC Cancer Protocol Summary for Palliative Combination ...
www.bccancer.bc.caBC Cancer Protocol Summary GIFIRINOX Page 1 of 10 Activated: 1 Jun 2011 Revised: 1 Oct 2021 (ST chair name, contact information, Eligibility and Caution s ... BC Cancer Protocol Summary for Palliative Combination Chemotherapy for Advanced Pancreatic Adenocarcinoma Using Irinotecan, Oxaliplatin, Fluorouracil and Leucovorin ... First line …
DOSE BANDING TABLES - Health Service Executive
www.hse.ie Oxaliplatin (v2) Rituximab (v2) Addition of new tables: Azacitidine (v1) Bortezomib 2.5mg/ml (v1) Bendamustine (v1) Cisplatin (v1) Cytarabine 100mg/ml (v1) Etoposide (v1) Methotrexate 100mg/ml (v1) Pembrolizumab (v1) Pemetrexed (v1) Vinorelbine (v1) Working Group 3 16/8/2018 Expansion of existing tables
大腸癌化学療法の変遷 - 新潟大学
www.med.niigata-u.ac.jpみで6-8 か月の時代から、5-fluorouracil (5-FU)、irinotecan (イリノテカン： CPT-11)、oxaliplatin (オキサリプラチン：L-OHP) といった抗癌剤の併用で延 長されてきた。さらに分子標的治療薬の導入で欧米との治療格差がなくなり、日
Clinical Practice Guidelines in Oncology (NCCN Guidelines ...
www2.tri-kobe.orgCOL-C 1 of 10 • Initial Therapy: 5-FU/leucovorin clarified with the addition of “infusional preferred”. COL-C 6 of 10 • The following footnotes removed: Discontinuation of oxaliplatin should be strongly considered from FOLFOX or CAPEOX after 3–4 months of therapy (or sooner if …
Specialty Pharmacy Drug List - Magellan Rx Management
magellanrx.comcapecitabine CAPRELSA PA carboplatin CERUBIDINE cisplatin cladribine CLOLAR COMETRIQ PA COSMEGEN cyclophosphamide CYRAMZA PA cytarabine dacarbazine DACOGEN DACTINOMYCIN ... oxaliplatin paclitaxel pentostatin PERJETA PA PHOTOFRIN POMALYST PA, QL PROLEUKIN PA PROVENGE PA PURIXAN PA REVLIMID PA, QL RITUXAN PA …
CANCER DRUG PHARMACOLOGY TABLE
www.bccancer.bc.caoxaliplatin (platinum) procarbazine (triazine) streptozocin (nitrosurea) temozolomide (triazine) thiotepa (aziridine) treosulfan Antimetabolites are structural analogues of naturally occurring molecules required for DNA and RNA synthesis. When substituted for the natural body
BC Cancer Protocol Summary for Palliative …
www.bccancer.bc.caBC Cancer Protocol Summary for Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Bevacizumab and Capecitabine
BC Cancer Protocol Summary for Palliative Combination ...
www.bccancer.bc.caBC Cancer Protocol Summary for Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil, Leucovorin, and PANitumumab
DRUG NAME: Oxaliplatin - BC Cancer
www.bccancer.bc.ca• QT prolongation and torsades de pointes are reported; use caution in patients with history of QT prolongation or cardiac disease and those receiving concurrent therapy with other QT prolonging
Similar queries
FOLFOX, Oxaliplatin, GEMOX +/-R Gemcitabine, Oxaliplatin +/- Rituximab, GEMOX +/-R (Gemcitabine, Oxaliplatin +/- Rituximab) for relapsed / refractory, SUMMARY OF PRODUCT CHARACTERISTICS 1, BC Cancer Protocol Summary for Palliative Combination, BC Cancer Protocol Summary, BC Cancer Protocol Summary for Palliative Combination Chemotherapy for Advanced Pancreatic Adenocarcinoma Using Irinotecan, Oxaliplatin, Fluorouracil, Fluorouracil, Guidelines, Leucovorin, Capecitabine, CANCER DRUG PHARMACOLOGY TABLE, Palliative Combination Chemotherapy for Metastatic Colorectal, Palliative Combination Chemotherapy for Metastatic, Oxaliplatin, Fluorouracil, Leucovorin, and PANitumumab, DRUG, QT prolongation